PHR Phreesia, Inc.
NYSE · SEC CIK 1412408 · EDGAR
- Bought, last 12 months
- $28.77M 2 purchases by 2 insiders
- Sold, last 12 months
- $2.18M 37 sales by 8 insiders
- Filings on record
- 566 since 2021-07-12, latest 2026-09-22 16:34
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Pale Fire Capital SICAV a.s. | 10% | $18.30M | — |
| Pale Fire Capital SE | 10% | $10.46M | — |
| Hoffman Allison C | GC, Sec | — | $537.1K |
| Indig Chaim | CEO, Dir | — | $421.0K |
| Linetsky David | Pres, Network Solutions | — | $347.2K |
| Gandhi Balaji | CFO | — | $291.8K |
| Roberts Evan | Pres, Provider Solutions | — | $281.9K |
| Hui Yvonne | Principal Accounting Off | — | $168.5K |
| VanDuyn Amy Beth | SVP, Human Resources | — | $105.8K |
| Egbuonu-Davis Lisa | Dir | — | $30.0K |
Transactions 672
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-14 | 2023-09-12 | PHR | Roberts Evan | COO | A - Grant | — | +6,559 | 751.7K | +0.9% | — | |
| M | 2023-09-14 | 2023-09-13 | PHR | Roberts Evan | COO | S - Sale | $20.34 | -3,907 | 747.8K | -0.5% | -$79.5K |
| 2023-09-14 | 2023-09-12 | PHR | Gandhi Balaji | CFO | A - Grant | — | +6,406 | 90.5K | +8% | — | |
| M | 2023-09-14 | 2023-09-13 | PHR | Gandhi Balaji | CFO | S - Sale | $20.34 | -3,957 | 86.7K | -4% | -$80.5K |
| T | 2023-09-14 | 2023-09-12 | PHR | Hoffman Allison C | GC, Sec | A - Grant | — | +5,466 | 121.8K | +5% | — |
| MT | 2023-09-14 | 2023-09-13+ | PHR | Hoffman Allison C | GC, Sec | S - Sale | $20.27 | -5,466 | 118.7K | -4% | -$110.8K |
| M | 2023-09-14 | 2023-09-13 | PHR | Indig Chaim | CEO, Dir | S - Sale | $20.34 | -6,555 | 1.25M | -0.5% | -$133.3K |
| 2023-09-14 | 2023-09-12 | PHR | Indig Chaim | CEO, Dir | A - Grant | — | +11.3K | 1.25M | +0.9% | — | |
| 2023-09-14 | 2023-09-12 | PHR | Gunzburg Janet | Principal Accounting Off | A - Grant | — | +2,404 | 42.1K | +6% | — | |
| M | 2023-09-14 | 2023-09-13 | PHR | Gunzburg Janet | Principal Accounting Off | S - Sale | $20.34 | -934 | 41.1K | -2% | -$19.0K |
| MT | 2023-09-14 | 2023-09-13+ | PHR | VanDuyn Amy Beth | SVP, Human Resources | S - Sale | $20.24 | -3,826 | 118.8K | -3% | -$77.5K |
| T | 2023-09-14 | 2023-09-12 | PHR | VanDuyn Amy Beth | SVP, Human Resources | A - Grant | — | +3,826 | 122.6K | +3% | — |
| DI | 2023-09-14 | 2023-09-12 | PHR | Linetsky David | SVP, Life Sciences | A - Grant | — | +273 | 8,081 | +3% | — |
| DM | 2023-09-14 | 2023-09-13 | PHR | Linetsky David | SVP, Life Sciences | S - Sale+OE | $20.34 | -2,059 | 217.1K | -0.9% | -$41.9K |
| DMI | 2023-09-14 | 2023-09-13 | PHR | Linetsky David | SVP, Life Sciences | S - Sale+OE | $20.34 | -119 | 7,962 | -1% | -$2,420 |
| D | 2023-09-14 | 2023-09-12 | PHR | Linetsky David | SVP, Life Sciences | A - Grant | — | +3,279 | 207.3K | +2% | — |
| DM | 2023-09-14 | 2023-09-12 | PHR | Linetsky David | SVP, Life Sciences | M - OptEx | $6.30 | +11.9K | 219.2K | +6% | +$74.7K |
| D | 2023-09-11 | 2023-09-08 | PHR | Roberts Evan | COO | M - OptEx | $2.03 | +30.0K | 745.2K | +4% | +$60.9K |
| 2023-08-28 | 2023-08-24 | PHR | Hoffman Allison C | GC, Sec | F - Tax | $26.39 | -11.0K | 116.3K | -9% | -$291.4K | |
| 2023-08-01 | 2023-07-31 | PHR | Munson Gillian | Dir | A - Grant | $31.72 | +315 | 25.7K | +1% | +$9,992 | |
| 2023-08-01 | 2023-07-31 | PHR | Goldstein Lainie | Dir | A - Grant | $31.72 | +315 | 30.1K | +1% | +$9,992 | |
| 2023-08-01 | 2023-07-31 | PHR | CAHILL EDWARD L | Dir | A - Grant | $31.72 | +315 | 44.5K | +0.7% | +$9,992 | |
| 2023-08-01 | 2023-07-31 | PHR | Gunzburg Janet | Principal Accounting Off | F - Tax | $31.72 | -272 | 39.6K | -0.7% | -$8,628 | |
| T | 2023-07-25 | 2023-07-21 | PHR | Davidoff Michael J. | SVP, Payer Business | S - Sale | $31.75 | -1,075 | 93.6K | -1% | -$34.1K |
| 2023-07-18 | 2023-07-14 | PHR | Gandhi Balaji | CFO | F - Tax | $33.72 | -807 | 84.1K | -1.0% | -$27.2K | |
| 2023-07-18 | 2023-07-14 | PHR | Hoffman Allison C | GC, Sec | F - Tax | $33.72 | -1,172 | 127.4K | -0.9% | -$39.5K | |
| 2023-07-18 | 2023-07-14 | PHR | Indig Chaim | CEO, Dir | F - Tax | $33.72 | -3,089 | 1.24M | -0.2% | -$104.2K | |
| 2023-07-18 | 2023-07-14 | PHR | Linetsky David | SVP, Life Sciences | F - Tax | $33.72 | -1,948 | 204.0K | -0.9% | -$65.7K | |
| 2023-07-18 | 2023-07-14 | PHR | Roberts Evan | COO | F - Tax | $33.72 | -1,781 | 715.2K | -0.2% | -$60.1K | |
| 2023-07-18 | 2023-07-14 | PHR | VanDuyn Amy Beth | SVP, Human Resources | F - Tax | $33.72 | -624 | 118.8K | -0.5% | -$21.0K | |
| 2023-07-18 | 2023-07-14 | PHR | Davidoff Michael J. | SVP, Payer Business | F - Tax | $33.72 | -1,122 | 94.7K | -1% | -$37.8K | |
| M | 2023-07-17 | 2023-07-13 | PHR | Egbuonu-Davis Lisa | Dir | A - Grant | $0.00 | +11.0K | 11.0K | New | $0 |
| 2023-07-10 | 2023-07-08 | PHR | Gandhi Balaji | CFO | F - Tax | $28.87 | -861 | 84.9K | -1% | -$24.9K | |
| 2023-07-05 | 2023-06-30 | PHR | Hoffman Allison C | GC, Sec | A - Grant | $26.21 | +201 | 128.5K | +0.2% | +$5,268 | |
| 2023-07-05 | 2023-06-30 | PHR | Gunzburg Janet | Principal Accounting Off | A - Grant | $26.21 | +148 | 39.9K | +0.4% | +$3,879 | |
| 2023-06-30 | 2023-06-28 | PHR | Weintraub Michael | Dir | A - Grant | $0.00 | +6,051 | 180.5K | +3% | $0 | |
| 2023-06-30 | 2023-06-28 | PHR | Sayar Ramin | Dir | A - Grant | $0.00 | +6,051 | 18.2K | +50% | $0 | |
| 2023-06-30 | 2023-06-28 | PHR | CAHILL EDWARD L | Dir | A - Grant | $0.00 | +6,051 | 44.2K | +16% | $0 | |
| 2023-06-30 | 2023-06-28 | PHR | Smith Mark Douglas | Dir | A - Grant | $0.00 | +6,051 | 22.2K | +38% | $0 | |
| 2023-06-30 | 2023-06-28 | PHR | Munson Gillian | Dir | A - Grant | $0.00 | +6,051 | 25.4K | +31% | $0 | |
| 2023-06-30 | 2023-06-28 | PHR | Goldstein Lainie | Dir | A - Grant | $0.00 | +6,051 | 29.7K | +26% | $0 | |
| MI | 2023-06-20 | 2023-06-15+ | PHR | Linetsky David | SVP, Life Sciences | F - Tax | $32.28 | -134 | 7,835 | -2% | -$4,326 |
| 2023-06-20 | 2023-06-17 | PHR | Gunzburg Janet | Principal Accounting Off | F - Tax | $31.79 | -117 | 39.8K | -0.3% | -$3,719 | |
| D | 2023-05-11 | 2023-05-09 | PHR | Indig Chaim | CEO, Dir | M - OptEx | $8.03 | +12.5K | 1.24M | +1% | +$100.0K |
| T | 2023-05-11 | 2023-05-10 | PHR | Munson Gillian | Dir | S - Sale | $30.06 | -3,555 | 19.3K | -16% | -$106.9K |
| 2023-05-03 | 2023-05-01 | PHR | Gunzburg Janet | Principal Accounting Off | F - Tax | $31.64 | -271 | 39.9K | -0.7% | -$8,574 | |
| 2023-05-01 | 2023-04-28 | PHR | Goldstein Lainie | Dir | A - Grant | $31.64 | +316 | 23.7K | +1% | +$9,998 | |
| 2023-05-01 | 2023-04-28 | PHR | Munson Gillian | Dir | A - Grant | $31.64 | +316 | 22.9K | +1% | +$9,998 | |
| 2023-05-01 | 2023-04-28 | PHR | CAHILL EDWARD L | Dir | A - Grant | $31.64 | +316 | 38.1K | +0.8% | +$9,998 | |
| T | 2023-04-25 | 2023-04-21 | PHR | Davidoff Michael J. | SVP, Payer Business | S - Sale | $33.13 | -1,075 | 95.8K | -1% | -$35.6K |
| T | 2023-04-20 | 2023-04-18 | PHR | Roberts Evan | COO | S - Sale | $32.09 | -7,452 | 717.0K | -1% | -$239.1K |
| T | 2023-04-18 | 2023-04-14 | PHR | Roberts Evan | COO | F - Tax | $31.64 | -1,781 | 727.0K | -0.2% | -$56.4K |
| T | 2023-04-18 | 2023-04-17 | PHR | Roberts Evan | COO | S - Sale | $32.01 | -2,600 | 724.4K | -0.4% | -$83.2K |
| T | 2023-04-18 | 2023-04-14 | PHR | Hoffman Allison C | GC, Sec | F - Tax | $31.64 | -1,172 | 131.6K | -0.9% | -$37.1K |
| T | 2023-04-18 | 2023-04-14 | PHR | Hoffman Allison C | GC, Sec | S - Sale | $31.16 | -3,306 | 128.3K | -3% | -$103.0K |
| 2023-04-18 | 2023-04-16 | PHR | Gunzburg Janet | Principal Accounting Off | A - Grant | $31.64 | +9,481 | 40.2K | +31% | +$300.0K | |
| 2023-04-18 | 2023-04-14 | PHR | Linetsky David | SVP, Life Sciences | F - Tax | $31.64 | -1,948 | 206.0K | -0.9% | -$61.6K | |
| I | 2023-04-18 | 2023-04-16 | PHR | Linetsky David | SVP, Life Sciences | A - Grant | $31.64 | +2,212 | 7,942 | +39% | +$70.0K |
| 2023-04-18 | 2023-04-14 | PHR | Davidoff Michael J. | SVP, Payer Business | F - Tax | $31.64 | -1,123 | 96.8K | -1% | -$35.5K | |
| 2023-04-18 | 2023-04-14 | PHR | Indig Chaim | CEO, Dir | F - Tax | $31.64 | -3,089 | 1.22M | -0.3% | -$97.7K | |
| T | 2023-04-18 | 2023-04-14 | PHR | Gandhi Balaji | CFO | F - Tax | $31.64 | -807 | 87.9K | -0.9% | -$25.5K |
| T | 2023-04-18 | 2023-04-17 | PHR | Gandhi Balaji | CFO | S - Sale | $31.83 | -2,113 | 85.7K | -2% | -$67.3K |
| D | 2023-04-18 | 2023-04-17 | PHR | VanDuyn Amy Beth | SVP, Human Resources | M - OptEx | $0.84 | +21.4K | 120.0K | +22% | +$18.0K |
| D | 2023-04-18 | 2023-04-17 | PHR | VanDuyn Amy Beth | SVP, Human Resources | S - Sale+OE | $31.84 | -570 | 119.4K | -0.5% | -$18.1K |
| D | 2023-04-18 | 2023-04-14 | PHR | VanDuyn Amy Beth | SVP, Human Resources | F - Tax | $31.64 | -623 | 98.6K | -0.6% | -$19.7K |
| T | 2023-04-13 | 2023-04-12 | PHR | Roberts Evan | COO | S - Sale | $32.01 | -200 | 728.8K | -0.0% | -$6,402 |
| 2023-04-12 | 2023-04-10 | PHR | Gunzburg Janet | Principal Accounting Off | F - Tax | $30.15 | -1,123 | 41.1K | -3% | -$33.9K | |
| 2023-04-12 | 2023-04-10 | PHR | Gunzburg Janet | Principal Accounting Off | A - Grant | — | +3,115 | 42.3K | +8% | — | |
| 2023-04-12 | 2023-04-10 | PHR | Roberts Evan | COO | A - Grant | — | +8,497 | 733.5K | +1% | — | |
| 2023-04-12 | 2023-04-10 | PHR | Roberts Evan | COO | F - Tax | $30.15 | -4,529 | 729.0K | -0.6% | -$136.5K | |
| 2023-04-12 | 2023-04-10 | PHR | Indig Chaim | CEO, Dir | A - Grant | — | +14.6K | 1.23M | +1% | — | |
| 2023-04-12 | 2023-04-10 | PHR | Indig Chaim | CEO, Dir | F - Tax | $30.15 | -7,885 | 1.22M | -0.6% | -$237.7K | |
| I | 2023-04-12 | 2023-04-10 | PHR | Linetsky David | SVP, Life Sciences | A - Grant | — | +210 | 5,793 | +4% | — |
| 2023-04-12 | 2023-04-10 | PHR | Linetsky David | SVP, Life Sciences | F - Tax | $30.15 | -1,800 | 207.9K | -0.9% | -$54.3K | |
| I | 2023-04-12 | 2023-04-10 | PHR | Linetsky David | SVP, Life Sciences | F - Tax | $30.15 | -63 | 5,730 | -1% | -$1,899 |
| 2023-04-12 | 2023-04-10 | PHR | Linetsky David | SVP, Life Sciences | A - Grant | — | +4,248 | 209.7K | +2% | — | |
| 2023-04-12 | 2023-04-10 | PHR | Gandhi Balaji | CFO | A - Grant | — | +4,956 | 91.5K | +6% | — | |
| 2023-04-12 | 2023-04-10 | PHR | Gandhi Balaji | CFO | F - Tax | $30.15 | -2,843 | 88.7K | -3% | -$85.7K | |
| T | 2023-04-12 | 2023-04-10 | PHR | Davidoff Michael J. | SVP, Payer Business | F - Tax | $30.15 | -3,615 | 101.4K | -3% | -$109.0K |
| T | 2023-04-12 | 2023-04-11 | PHR | Davidoff Michael J. | SVP, Payer Business | S - Sale | $30.91 | -3,466 | 98.0K | -3% | -$107.1K |
| T | 2023-04-12 | 2023-04-10 | PHR | Davidoff Michael J. | SVP, Payer Business | A - Grant | — | +7,081 | 105.1K | +7% | — |
| 2023-04-12 | 2023-04-10 | PHR | Hoffman Allison C | GC, Sec | F - Tax | $30.15 | -3,775 | 132.8K | -3% | -$113.8K | |
| 2023-04-12 | 2023-04-10 | PHR | Hoffman Allison C | GC, Sec | A - Grant | — | +7,081 | 136.6K | +5% | — | |
| 2023-04-12 | 2023-04-10 | PHR | VanDuyn Amy Beth | SVP, Human Resources | A - Grant | — | +4,956 | 101.4K | +5% | — | |
| 2023-04-12 | 2023-04-10 | PHR | VanDuyn Amy Beth | SVP, Human Resources | F - Tax | $30.15 | -2,196 | 99.2K | -2% | -$66.2K | |
| DMT | 2023-04-05 | 2023-04-03 | PHR | Smith Mark Douglas | Dir | S - Sale+OE | $30.77 | -7,000 | 16.6K | -30% | -$215.4K |
| DT | 2023-04-05 | 2023-04-03 | PHR | Smith Mark Douglas | Dir | M - OptEx | $4.71 | +7,000 | 23.1K | +43% | +$33.0K |
| MT | 2023-04-05 | 2023-04-03 | PHR | VanDuyn Amy Beth | SVP, Human Resources | S - Sale | $30.79 | -2,978 | 96.5K | -3% | -$91.7K |
| 2023-03-28 | 2023-03-24 | PHR | Gandhi Balaji | CFO | A - Grant | $0.00 | +21.4K | 86.5K | +33% | $0 | |
| A | 2023-03-23 | 2022-05-09 | PHR | Munson Gillian | Dir | F - Tax | $16.54 | -1,449 | 18.9K | -7% | -$24.0K |
| MI | 2023-03-20 | 2023-03-15+ | PHR | Linetsky David | SVP, Life Sciences | F - Tax | $34.61 | -236 | 5,557 | -4% | -$8,169 |
| 2023-02-06 | 2023-02-02 | PHR | VanDuyn Amy Beth | SVP, Human Resources | S - Sale | $40.00 | -300 | 99.5K | -0.3% | -$12.0K | |
| 2023-02-06 | 2023-02-02 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $39.55 | -11.4K | 205.5K | -5% | -$450.0K | |
| M | 2023-02-06 | 2023-02-02 | PHR | Davidoff Michael J. | SVP, Payer Business | S - Sale | $39.21 | -7,513 | 99.5K | -7% | -$294.6K |
| 2023-02-06 | 2023-02-02 | PHR | Rasmussen Randy | CFO | S - Sale | $40.00 | -4,765 | 145.6K | -3% | -$190.6K | |
| 2023-02-02 | 2023-01-31 | PHR | CAHILL EDWARD L | Dir | A - Grant | $37.49 | +266 | 37.8K | +0.7% | +$9,972 | |
| 2023-02-02 | 2023-01-31 | PHR | Munson Gillian | Dir | A - Grant | $37.49 | +266 | 22.6K | +1% | +$9,972 | |
| 2023-02-02 | 2023-01-31 | PHR | Goldstein Lainie | Dir | A - Grant | $37.49 | +266 | 23.4K | +1% | +$9,972 | |
| DM | 2023-01-31 | 2023-01-30+ | PHR | Davidoff Michael J. | SVP, Payer Business | S - Sale+OE | $36.30 | -31.8K | 108.7K | -23% | -$1.15M |
| DM | 2023-01-31 | 2023-01-30 | PHR | Davidoff Michael J. | SVP, Payer Business | M - OptEx | $7.83 | +12.1K | 136.6K | +10% | +$94.7K |
Purchase Sale Sale after option exercise All abbreviations